Diagnostic Test Accuracy of Commercial Tests for Detection of Shiga Toxin–Producing Escherichia coli: A Systematic Review and Meta-Analysis
Open Access
- 29 January 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 66 (2) , 302-315
Abstract
Rapid detection of Shiga toxin–producing Escherichia coli (STEC) enables appropriate monitoring and treatment. We synthesized available evidence to compare the performance of enzyme immunoassay (EIA) and PCR tests for the detection of STEC. We searched published and gray literature for studies of STEC EIA and/or PCR diagnostic test accuracy relative to reference standards including at least one nucleic acid amplification test. Two reviewers independently screened studies, extracted data, and assessed quality with the second version of the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. Bivariate random effects models were used to meta-analyze the clinical sensitivity and specificity of commercial EIA and PCR STEC diagnostic tests, and summary receiver operator characteristic curves were constructed. We evaluated the certainty of evidence with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. We identified 43 articles reflecting 25 260 specimens. Meta-analysis of EIA and PCR accuracy included 25 and 22 articles, respectively. STEC EIA pooled sensitivity and specificity were 0.681 (95% CI, 0.571–0.773; very low certainty of evidence) and 1.00 (95% CI, 0.998–1.00; moderate certainty of evidence), respectively. STEC PCR pooled sensitivity and specificity were 1.00 (95% CI, 0.904–1.00; low certainty of evidence) and 0.999 (95% CI, 0.997–0.999; low certainty of evidence), respectively. Certainty of evidence was downgraded because of high risk of bias. PCR tests to identify the presence of STEC are more sensitive than EIA tests, with no meaningful loss of specificity. However, given the low certainty of evidence, our results may overestimate the difference in performance.Keywords
Funding Information
- BioMérieux and Luminex. L. Chui
- Alberta Children s Hospital Foundation Professorship in Child Health and Wellness
- Alberta Innovates Team Collaborative Research Innovation Opportunity
This publication has 57 references indexed in Scilit:
- Clinical and Laboratory Predictors of Shiga Toxin–Producing Escherichia coli Infection in Children With Bloody DiarrheaJournal of the Pediatric Infectious Diseases Society, 2018
- Associations Between Hydration Status, Intravenous Fluid Administration, and Outcomes of Patients Infected With Shiga Toxin–Producing Escherichia coliJAMA Pediatrics, 2017
- Real-Time PCR Assay for Detection and Differentiation of Shiga Toxin-Producing Escherichia coli from Clinical SamplesJournal of Clinical Microbiology, 2015
- Evaluation of Enzyme Immunoassays and Real-Time PCR for Detecting Shiga Toxin-Producing Escherichia coli in Southern Alberta, CanadaJournal of Clinical Microbiology, 2015
- Outbreaks of non-O157 Shiga toxin-producingEscherichia coliinfection: USAEpidemiology and Infection, 2014
- Increased Recognition of Non-O157 Shiga Toxin–Producing Escherichia coli Infections in the United States During 2000–2010: Epidemiologic Features and Comparison with E. coli O157 InfectionsFoodborne Pathogens and Disease, 2013
- Risk Factors for the Hemolytic Uremic Syndrome in Children Infected With Escherichia coli O157:H7: A Multivariable AnalysisClinical Infectious Diseases, 2012
- Antibiotic Treatment of Escherichia coli O157 Infection and the Risk of Hemolytic Uremic Syndrome, MinnesotaThe Pediatric Infectious Disease Journal, 2012
- Rapid and Sensitive Detection of Shiga Toxin-Producing Escherichia coli from Nonenriched Stool Specimens by Real-Time PCR in Comparison to Enzyme Immunoassay and CultureJournal of Clinical Microbiology, 2009
- Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitisJournal of Clinical Microbiology, 1986